Clinical Observation of 2 Cases of Recurrent Breast Cancer Treated by Hyperthermia Combined with Radiotherapy and Chemotherapy
Abstract: Background: Hyperthermia is widely used in the treatment of some malignant tumors, especially for the tumor patients who are not sensitive to radiotherapy and chemotherapy. The sensitivity of tumor patients to conventional radiotherapy and chemotherapy can be improved by the aid of hyperthermia. Case Report: We reported two cases of recurrent breast cancer after radical mas-tectomy, found in the subcutaneous superficial soft tissue in the axillary region, and the effect of chemotherapy on the recurrence and metastasis was not obvious. Subsequently, we combined with the application of radiotherapy and chemotherapy; the tumor cells were significantly reduced, and the pathological biopsy showed obvious necrosis of tumor cells. Patients’ quality of life has been improved. Conclusion: Hyperthermia can effectively improve the sensitivity of conventional radiotherapy and chemotherapy in some tumors, and provide new therapeutic approach for the treatment of cancer patients with no sensitiveness.
文章引用: 马燕凌 , 孙建海 , 晏菲 (2015) 热疗联合放化疗治疗乳腺癌皮肤复发病例2例临床病理观察。 亚洲肿瘤科病例研究， 4， 15-19. doi: 10.12677/ACRPO.2015.43003
Alphandery, E. (2014) Perspectives of breast cancer thermotherapies. Journal of Cancer, 5, 472-479.
Vogl, T.J., et al. (2013) Thermal ablation therapies in patients with breast cancer liver metastases: A review. European Radiology, 23, 797-804.
 Takeda, T., et al. (2013) The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer. Gan To Kagaku Ryoho, 40, 1596-1599.
Linthorst, M., et al. (2013) Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiotherapy & Oncology, 109, 188-193.
Sersa, G., et al. (2012) Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treatment Reviews, 38, 379-386.
Lee, H., et al. (2014) Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined. PLoS ONE, 9, e87979.